Who owns Context Therapeutics Inc.?

No ownership or control links for Context Therapeutics Inc. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Context Therapeutics Inc.'s risk level?

WhiteIntel flags Context Therapeutics Inc. as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Context Therapeutics Inc. appear across sources?

Context Therapeutics Inc. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Coverage — measured

Ownership hops held: 24

An absent edge means not yet observed — never does not exist.

Legal entityMedium

Context Therapeutics Inc.

Name: Context Therapeutics Inc. — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Context Therapeutics Inc., Company, US

Context Therapeutics Inc. — US company (sec:0001842952). UBO chain traced 24 hops. Every claim linked to its source.

SEC 0001842952CompanyUS

Ownership graph Export .md

JSON / MCPsample

The finding

Ownership resolves 24 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

No ownership or control links resolved yet

An absent link means “not yet observed in our current sources”, not that none exists — cross-source resolution is still growing.

Watch this entity

We flag the moment ownership, a filing or a sanctions signal lands on it — the fastest way to catch a change on a subject we hold little on today.

United States coverage Report a lead Expand in the graph

Walk the full UBO chain

24 hops lockedSTANDARD

24-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Standard Dossier€39

Standard Dossier€39

The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.

Everything we hold on Context Therapeutics Inc., resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK

UBO trace
Branded PDF + un-redacted JSON · every claim linked to its source
Re-download for 90 days

UBO trace

Guest checkout · email only · re-download 90 days. Or subscribe from €149.

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

YOURS AFTER YOU UNLOCK · PAID

2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

Full ownership trace to the UBOSTANDARD
Full export (PDF + un-redacted JSON) & change alertsPREMIUM

/02

People & control

8 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
BERMAN RICHARD J
Also holds roles at 23 other companies
- BIOVIE INC.director
- Celularity Incdirector
- EASYLINK SERVICES INTERNATIONAL CORPdirector
●
KANTOFF PHILIP W.
Also holds roles at 1 other company
- ESSA PHARMA INC.director
●
Minai-Azary Jennifer Lynn
Also holds roles at 1 other company
- Tempest Therapeutics, Inc.officer
●
Pasternak Andy
Also holds roles at 2 other companies
- KARDIGAN, INC.officer
- HORIZON PHARMA PLCofficer
●
Smith Karen L.
Also holds roles at 10 other companies
- Skye Bioscience, Inc.director
- SANGAMO THERAPEUTICS, INCdirector
- Aurinia Pharmaceuticals Inc.director
●
STACEY JENNIFER EVANS
Also holds roles at 4 other companies
- NEOGEN CORPofficer
- Galera Therapeutics, Inc.officer
- ANTARES PHARMA INCofficer
●
Walker Luke Nathaniel
Also holds roles at 3 other companies
- Zentalis Pharmaceuticals, Inc.director
- HARPOON THERAPEUTICS, INC.officer
- BIOMIRA CORPofficer
●
WEST LINDA
Also holds roles at 1 other company
- Galera Therapeutics, Inc.director

8 parties · 0 current. Ceased and resigned records are retained as history.

/03

Common questions

Who owns Context Therapeutics Inc.?: No ownership or control links for Context Therapeutics Inc. are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is Context Therapeutics Inc.'s risk level?: WhiteIntel flags Context Therapeutics Inc. as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does Context Therapeutics Inc. appear across sources?: Context Therapeutics Inc. is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on Context Therapeutics Inc.. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…